Wei Qiao Qiu1,2,3, Jayandra J Himali4,5, Philip A Wolf4,5, D Charles DeCarli6, Alexa Beiser4,5,7, Rhoda Au4,5. 1. Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA. 2. Department of Pharmacology, Boston University School of Medicine, Boston, MA, USA. 3. Alzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA. 4. Department of Neurology, Boston University School of Medicine, Boston, MA, USA. 5. Framingham Heart Study, Boston University School of Public Health, Boston, MA, USA. 6. Alzheimer's Disease Center, University of California Davis Medical Center, Sacramento, CA, USA. 7. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: It is unclear whether brain white matter hyperintensities (WMHI) causes or is a result of late life depression. We used the Framingham Heart Study offspring to examine whether indices of brain aging are related to incident depression in the elderly. METHODS: The Center for Epidemiologic Studies Depression Scale (CES-D) was administered along with a brain MRI scan at baseline and was re-administered (n = 1212) at an average 6.6 + 0.6 year follow-up. The outcomes (i) change in CES-D scores from baseline; (ii) depression defined as CES-D ≥16; (iii) severe depression defined as CES-D ≥21; and (iv) CES-D cutoff scores and/or on antidepressant were used. RESULTS: Among those who did not have depression at baseline, 9.1% (n = 110) developed depression, 4.0% (n = 48) developed severe depressive symptoms, and 11.1% (n = 135) were put on antidepressants. When depressive symptoms only was the outcome, we found that baseline WMHI was positively associated with change in CES-D scores and that those with an extensive WMHI at baseline had a high risk of developing severe depressive symptoms; the relationship was strengthened in the absence of cardiovascular diseases. In contrast, when depressive symptoms or taking antidepressant was the outcome, larger total cerebral brain volume and temporal lobe brain volume, but not WMHI, were negatively associated with the development of depression. CONCLUSIONS: Brain WMHI is a probable risk factor for vascular depression in the elderly. The depression outcomes with and without antidepressant were related to different brain pathologies.
BACKGROUND: It is unclear whether brain white matter hyperintensities (WMHI) causes or is a result of late life depression. We used the Framingham Heart Study offspring to examine whether indices of brain aging are related to incident depression in the elderly. METHODS: The Center for Epidemiologic Studies Depression Scale (CES-D) was administered along with a brain MRI scan at baseline and was re-administered (n = 1212) at an average 6.6 + 0.6 year follow-up. The outcomes (i) change in CES-D scores from baseline; (ii) depression defined as CES-D ≥16; (iii) severe depression defined as CES-D ≥21; and (iv) CES-D cutoff scores and/or on antidepressant were used. RESULTS: Among those who did not have depression at baseline, 9.1% (n = 110) developed depression, 4.0% (n = 48) developed severe depressive symptoms, and 11.1% (n = 135) were put on antidepressants. When depressive symptoms only was the outcome, we found that baseline WMHI was positively associated with change in CES-D scores and that those with an extensive WMHI at baseline had a high risk of developing severe depressive symptoms; the relationship was strengthened in the absence of cardiovascular diseases. In contrast, when depressive symptoms or taking antidepressant was the outcome, larger total cerebral brain volume and temporal lobe brain volume, but not WMHI, were negatively associated with the development of depression. CONCLUSIONS: Brain WMHI is a probable risk factor for vascular depression in the elderly. The depression outcomes with and without antidepressant were related to different brain pathologies.
Authors: B D Lebowitz; J L Pearson; L S Schneider; C F Reynolds; G S Alexopoulos; M L Bruce; Y Conwell; I R Katz; B S Meyers; M F Morrison; J Mossey; G Niederehe; P Parmelee Journal: JAMA Date: 1997-10-08 Impact factor: 56.272
Authors: Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy Journal: Arch Gen Psychiatry Date: 2010-03
Authors: Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf Journal: Neurobiol Aging Date: 2005-04 Impact factor: 4.673
Authors: Michael A Rapp; Karen Dahlman; Mary Sano; Hillel T Grossman; Vahram Haroutunian; Jack M Gorman Journal: Am J Psychiatry Date: 2005-04 Impact factor: 18.112
Authors: Howard J Aizenstein; Carmen Andreescu; Kathryn L Edelman; Jennifer L Cochran; Julie Price; Meryl A Butters; Jordan Karp; Meenal Patel; Charles F Reynolds Journal: Am J Psychiatry Date: 2011-07-28 Impact factor: 18.112
Authors: Warren D Taylor; David C Steffens; James R MacFall; Douglas R McQuoid; Martha E Payne; James M Provenzale; K Ranga Rama Krishnan Journal: Arch Gen Psychiatry Date: 2003-11
Authors: K Takahashi; A Oshima; I Ida; H Kumano; N Yuuki; M Fukuda; M Amanuma; K Endo; M Mikuni Journal: J Psychiatr Res Date: 2007-06-22 Impact factor: 4.791
Authors: Mitzi M Gonzales; Jasmeet Samra; Adrienne O'Donnell; R Scott Mackin; Joel Salinas; Mini E Jacob; Claudia L Satizabal; Hugo J Aparicio; Emma G Thibault; Justin S Sanchez; Rebecca Finney; Zoe B Rubinstein; Danielle V Mayblyum; Ron J Killiany; Charlie S Decarli; Keith A Johnson; Alexa S Beiser; Sudha Seshadri Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Howard J Aizenstein; Andrius Baskys; Maura Boldrini; Meryl A Butters; Breno S Diniz; Manoj Kumar Jaiswal; Kurt A Jellinger; Lev S Kruglov; Ivan A Meshandin; Milija D Mijajlovic; Guenter Niklewski; Sarah Pospos; Keerthy Raju; Kneginja Richter; David C Steffens; Warren D Taylor; Oren Tene Journal: BMC Med Date: 2016-11-03 Impact factor: 8.775
Authors: Catherine A Spilling; Mohani-Preet K Bajaj; Daniel R Burrage; Sachelle Ruickbie; N Jade Thai; Emma H Baker; Paul W Jones; Thomas R Barrick; James W Dodd Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-08-21
Authors: Christian Puzo; Caroline Labriola; Michael A Sugarman; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Thor D Stein; Neil W Kowall; Ann C McKee; Jesse Mez; Ronald J Killiany; Robert A Stern; Michael L Alosco Journal: Alzheimers Res Ther Date: 2019-07-27 Impact factor: 6.982